IDiyas

For the Inventor, By the Inventor

Skovlunde, Denmark

Mauro Marigo

USPTO Granted Patents = 39 

 

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 113(Granted Patents)


Location History:

  • Valby, DK (2018 - 2022)
  • Skovlunde, DK (2013 - 2023)

Company Filing History:

goldMedal39 out of 506 
 
H. Lundbeck A/s
 patents

Years Active: 2013-2024

Loading Chart...
Loading Chart...
39 patents (USPTO):Explore Patents
1. 12129289 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2024-10-29),
2. 11851425 - Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines (2023-12-26),
3. 11634416 - Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines (2023-04-25),
4. 11535611 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2022-12-27),
5. 11491140 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2022-11-08),
6. 11466027 - Modulators of the NMDA receptor (2022-10-11),
7. 11358971 - Prodrugs of modulators of the NMDA receptor (2022-06-14),
8. 11111290 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2021-09-07),
9. 11104680 - 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors (2021-08-31),
10. 11026924 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),
11. 11026923 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2021-06-08),
12. 10806718 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-10-20),
13. 10766893 - 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors (2020-09-08),
14. 10689379 - Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors (2020-06-23),
15. 10647762 - Antibodies specific for hyperphosphorylated tau and methods of use thereof (2020-05-12),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I would be happy to assist you in crafting an article about inventor Mauro Marigo.

Title: The Inventive Mind of Mauro Marigo: A Pioneer in Neurodegenerative Treatments

Introduction: Mauro Marigo, hailing from Skovlunde, Denmark, is a prolific inventor with a remarkable portfolio of 38 patents. His groundbreaking work has significantly impacted the fields of neurodegenerative and cognitive disorders.

Latest Patents:

Mauro Marigo's latest patents revolve around the innovative concept of combination treatments comprising the administration of 1H-pyrazolo[4,3-B]pyridines. These patents provide 1H-pyrazolo[4,3-b]pyridin-7-amines as PDE1 inhibitors, along with a second compound tailored for the treatment of neurodegenerative and psychiatric disorders. This unique approach highlights Marigo's dedication to advancing treatment options for complex medical conditions.

Career Highlights:

Currently a key figure at H. Lundbeck A/S, Marigo's inventive spirit thrives in a dynamic environment focused on pharmaceutical innovations. His role at Lundbeck showcases his commitment to pioneering solutions that enhance the quality of patient care and improve treatment outcomes.

Collaborations:

In his professional journey, Mauro Marigo has collaborated closely with esteemed colleagues such as Karsten Juhl and Jan Kehler. These partnerships have been instrumental in pushing the boundaries of pharmaceutical research and development, fostering a culture of innovation and excellence.

Conclusion:

Mauro Marigo's innovative contributions to the healthcare industry underscore his passion for addressing unmet medical needs and improving patient well-being. Through his relentless pursuit of novel treatment approaches, Marigo continues to shape the landscape of neurodegenerative and cognitive disorder treatments, leaving a lasting impact on the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…